Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-14-000735

Director acquired 18,818 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CANNON JAMES ANTHONY Director 2013-12-31 Grant or award +18,818 294,976 D
Loading xslF345X03/doc4.xml…